AcuraStem is a pre-clinical stage, patient-focused biotechnology company translating cutting-edge science into transformative therapies for neurodegenerative diseases. By combining proprietary iPSC-based disease modeling with a deep commitment to rigorous science, AcuraStem is building a pipeline of precision medicines with the goal of bringing new hope to patients afflicted with devastating diseases. Our translational approach integrates human-based discovery, biomarker development, and therapeutic advancement, enabling a direct path from bench to bedside. We are a team of curious, driven, and collaborative scientists who value high integrity, quality data, and reproducibility. At AcuraStem, every experiment contributes to our mission of accelerating therapies into the clinic.

Apeximmune Therapeutics is pioneering a new generation of therapeutic antibodies and biologics that harness the power of the immune system to deliver curative treatments for cancer and autoimmune disease. We leverage our target discovery and validation platform to uncover proprietary insights into novel immune modulating targets and pathways, to which we develop drug candidates designed to either enhance or subdue immune function for therapeutic effect. We are driven by the potential to positively impact human life with meaningful medicines, while always being guided by the biology and rigorous science. The Apeximmune team encompasses expertise in immunology, cellular and molecular tumor biology, antibody generation, protein characterization and engineering, and the regulatory process.

Altechna R&D, brand name Workshop of Photonics (WOP) is a Lithuanian-based high-tech company specializing in femtosecond laser micromachining, with over two decades of experience in delivering ultra-precise solutions for industrial and scientific applications. The company is renowned for its expertise in glass processing, transparent materials, and custom laser system development.

Chain Reaction (https://www.chain-reaction.io/) is engineering the future of disruptive blockchain and privacy technologies. We accelerate compute performance, enabling companies to adopt and scale solutions to the world’s most complex problems. Partnering with cloud and data centers, we transform compute infrastructure with custom ASICs and systems that optimize for energy efficient, high-performance compute. Our 3PU™ (Privacy Processor) dramatically accelerates real-time operations of Privacy Enhancing Technologies on encrypted data, transforming the cloud into a trusted environment, enabling verticals that rely on confidential big data to use the cloud (including financial institutions, healthcare & big pharma, defense & government, and oil & gas). Purpose-built and custom-designed, our solutions power the next generation of secure, scalable, green computing to help protect people, privacy, and the planet.

Cellentia is leveraging cancer organoids to identify drugs that can cure metastatic cancers. We are specialized in bioassays using patient-derived cancer organoids.

Based in San Diego, Kneron Inc. is a start-up dedicated to local/edging AI solutions. Kneron was the winner of Tengfei Award by Tencent and won the third place in Innovation Competition of International Talents, Silicon Valley Division.

We are an AI biotech company focused on developing small molecule therapeutics in the immunology space. Our platform is a ligand-based large language model, which currently can inference >5B synthesizable compounds.

MSS USA CORP, established in May 2024, is a subsidiary of MSSCORPS CO., LTD. We uphold our parent company’s tradition of delivering precise and prompt analytic services with exceptional quality to clients in the semiconductor industry, positioning ourselves as the premier R&D partner in this sector. Our core service is Transmission Electron Microscopy (TEM) analysis, which provides comprehensive structural (TEM/STEM imaging modes), chemical (EDS), and dimensional (auto CD measurements) information on materials of interest. Leveraging our proprietary and patented sample protection strategy, along with advanced FIB sample preparation techniques, we offer accurate TEM analysis for both hard and fragile materials used in cutting-edge technology developments, such as low-k dielectrics and EUV photoresists. This specialized analytic method furnishes R&D engineers with crucial insights, accelerating their development processes. We recognize that the protection of proprietary information (PIP) is of utmost importance. MSS USA adheres to the same rigorous PIP control procedures as its parent company, which has earned the trust and recognition of numerous world-renowned semiconductor companies. Every piece of information, including provided materials, samples, data, and analytic history, is meticulously recorded, securely stored, and robustly protected. MSS USA remains a trusted R&D metrology partner for companies that prioritize the safeguarding of their proprietary information. By expanding into the US market, we bring our expertise closer to our clients, enhancing collaboration and fostering innovation across the semiconductor industry.

Onyx Healthcare USA is a subsidiary of the ASUS Computer Group that has been providing innovative and medically certified (CE/FCC Class B,UL/EN60601, CSA) healthcare computing solutions to assist workflows in operating suites, nursing stat ions, patient wards, ambulatory care, and hospital administrations worldwide. Onyx Healthcare USA, Inc., with 15+ years of medical design experiences, leverages embedded computing technology to design and manufacture medical grade (UL60601-1) fanless all-in-one panel system platforms and embedded boards as the building blocks to medical device OEM and healthcare IT business.

At Polaris Electro-Optics, Inc., we believe that overcoming society’s greatest challenges requires mastery of the creation, movement, and use of information. We are mastering the movement of information by leveraging patented material and design innovations to offer the highest-speed, most energy efficient integrated photonics products to the communications and computation industries. Our goal is to define the standard for moving information. We work hard in a collaborative, cross-functional team environment, and value mutual trust and respect built on a foundation of integrity, transparency, consistency, and humility. Additional information about Polaris is available at www.PolarisEO.com.

PathCision Medicine is a biopharmaceutical startup using tissue pathology data to develop novel precision medicine for metastatic cancer and other diseases. Our proprietary AI drug discovery engine deciphers how diseases interact within the tissue microenvironment, and we integrate advanced patient multi-omic data to ensure clinical translatability. The first asset that emerged from this engine can home into tumors and avoid healthy tissue – limiting toxicity while increasing efficacy. We are now building version 2 of the discovery engine to increase the machine learning component and are seeking to grow our team with additional machine learning engineers.

PharmaEssentia is a global biopharmaceutical company founded in 2003 by Taiwanese-American executives and scientists. Its mission is to develop innovative therapies for serious diseases Global Footprint & Facilities Headquarters: Taipei, Taiwan U.S. Hub: Bedford, Massachusetts, home to the PharmaEssentia Innovation Research Center (PIRC), which focuses on drug discovery for rare cancers Manufacturing: A world-class biologics facility in Taichung, Taiwan, certified by the TFDA and compliant with U.S. FDA and EMA standards

Syncell is a life science technology company providing unique solutions to next-generation proteomics, unbiased, deep, spatially precise, highly sensitive, and highly specific all in one. Established in 2020, Syncell quickly launched its first Microscoop® platform Microscoop Mint and proprietary reagents Synlight™ and Synpull™ in 2024 to fill the gap of high-precision microscopy-guided proteomic discovery. The technology was designed to address the pain points of biological researchers in breadth, enabling microscopy-guided spatial protein purification and proteomic discovery at any visually recognizable regions of interest. Our commercial team is working tightly with the customers, and together with the R&D and production teams to maximize our customer’s success in discovering key protein players for specific problems of interest.

Taboola (a Nasdaq company) powers recommendations for the open web, helping people discover things they may like. The company’s platform, powered by artificial intelligence, is used by digital properties, including websites, devices and mobile apps, to drive monetization and user engagement. Taboola has long-term partnerships with some of the top digital properties in the world, including Yahoo, CNBC, BBC, NBC News, Business Insider, The Independent and El Mundo. Around 18,000 advertisers use Taboola to reach nearly 600 million daily active users in a brand-safe environment. Taboola is a leader in powering e-commerce recommendations, driving more than 1 million monthly transactions, with leading brands including Walmart, Macy’s, Skechers and eBay among key customers.

Tachyum is a fabless semiconductor company developing the world’s first Universal Processor, Prodigy, which unifies the functionality of CPU, GPGPU, and TPU into a single monolithic device, delivering unprecedented performance, power efficiency, and TCO reduction for a wide range of applications and workloads, including cloud AI, and HPC. Prodigy’s revolutionary architecture solves key issues that are plaguing today’s data centers, including high power consumption and low server utilization. With Prodigy, hyperscale data centers can run cloud workloads during peak hours and AI workloads during off hours, keeping servers running 24/7. Prodigy eliminates the need for costly and power-hungry accelerators, enabling high performance data centers to be deployed with a homogeneous architecture, enabling a simple software model and easy, straightforward maintenance. Tachyum has approximately 100 employees with engineering teams in the Silicon Valley, Slovakia, the Czech Republic, and the corporate office in Nevada, Las Vegas.

Vizuro is an innovator and solution provider of Multimodal, Causal AI with its powerful applications in diverse sectors. We utilize our proprietary self-learning, explainable and actionable AI on a managed, data-science-as-a-service platform to quickly deploy bespoke applications in an expedited timeframe. We serve global clients in various sectors and sizes, ranging from Fortune 100 enterprises to startups